Read More
Study uses metabolomics to discriminate drug-induced liver injury phenotypes
Drug-induced liver injury (DILI) is an adverse reaction to ingesting a drug, which can appear both in developmental stages, in their clinical use and even after being approved as a drug.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Read More
- Researchers discover how the sponginess of stem cell nuclei controls cell differentiation
- Researchers warn about the dangers of vitamin B12 deficiency in people following plant-based diets
- APOE4 allele gene linked to increased risk of severe COVID-19
- Healthy dietary habits help reduce risk of gestational diabetes mellitus in pregnant women
Subscribe to:
Post Comments (Atom)
0 Response to "Study uses metabolomics to discriminate drug-induced liver injury phenotypes"
Post a Comment